These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37888650)

  • 1. A Narrative Literature Review of the Established Safety of Human Serum Albumin Use as a Stabilizer in Aesthetic Botulinum Toxin Formulations Compared to Alternatives.
    Sattler S; Gollomp S; Curry A
    Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety verification for polysorbate 20, pharmaceutical excipient for intramuscular administration, in Sprague-Dawley rats and New Zealand White rabbits.
    Kim J; Kwak S; Park MS; Rhee CH; Yang GH; Lee J; Son WC; Kang WH
    PLoS One; 2021; 16(8):e0256869. PubMed ID: 34449810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.
    Chen JJ; Dashtipour K
    Pharmacotherapy; 2013 Mar; 33(3):304-18. PubMed ID: 23400888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-Infrared Transflectance Spectroscopy Discriminates Solutions Containing Two Commercial Formulations of Botulinum Toxin Type A Diluted at Recommended Volumes for Clinical Reconstitution.
    Currà A; Gasbarrone R; Bonifazi G; Serranti S; Fattapposta F; Trompetto C; Marinelli L; Missori P; Lendaro E
    Biosensors (Basel); 2022 Apr; 12(4):. PubMed ID: 35448275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products.
    Kutschenko A; Bigalke H; Wegner F; Wohlfarth K
    Toxicon; 2019 Oct; 168():158-163. PubMed ID: 31323228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons among botulinum toxins: an evidence-based review.
    Klein AW; Carruthers A; Fagien S; Lowe NJ
    Plast Reconstr Surg; 2008 Jun; 121(6):413e-422e. PubMed ID: 18520868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
    Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport®).
    Pons L; Vilain C; Volteau M; Picaut P
    J Neurol Sci; 2019 Dec; 407():116516. PubMed ID: 31655410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of proteolytic activity following reduction in therapeutic human serum albumin containing products: detection with a new neoepitope endopeptidase immunoassay.
    Jones RG; Liu Y; Halls C; Thorpe SJ; Longstaff C; Matejtschuk P; Sesardic D
    J Pharm Biomed Anal; 2011 Jan; 54(1):74-80. PubMed ID: 20832960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications.
    Carr WW; Jain N; Sublett JW
    Adv Ther; 2021 Oct; 38(10):5046-5064. PubMed ID: 34515975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic interventions for treating phantom limb pain.
    Alviar MJ; Hale T; Dungca M
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD006380. PubMed ID: 27737513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
    Dolimbek BZ; Jankovic J; Atassi MZ
    Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin: Preparations for Clinical Use, Immunogenicity, Side Effects, and Safety Profile.
    Dashtipour K; Pedouim F
    Semin Neurol; 2016 Feb; 36(1):29-33. PubMed ID: 26866493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in cancer therapy-current perspectives and limitations.
    Grenda T; Grenda A; Krawczyk P; Kwiatek K
    Appl Microbiol Biotechnol; 2022 Jan; 106(2):485-495. PubMed ID: 34951660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of facial cosmetic botulinum toxin A injection: analysis of the UK Medicines & Healthcare Products Regulatory Agency registry and literature review.
    Zargaran D; Zoller FE; Zargaran A; Mosahebi A
    J Plast Reconstr Aesthet Surg; 2022 Jan; 75(1):392-401. PubMed ID: 34456155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Safety of Polysorbates in Drug Formulations.
    Kriegel C; Festag M; Kishore RSK; Roethlisberger D; Schmitt G
    Children (Basel); 2019 Dec; 7(1):. PubMed ID: 31877624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).
    Kane CD; Nuss JE; Bavari S
    Expert Opin Ther Pat; 2015 Jun; 25(6):675-90. PubMed ID: 25842964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.